Participants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement ...

Stage 1 hypertension: SBP 140-159 or DBP 90-99 Stage 2 hypertension ... For patients with hypertension, the basic BP-control target is <140/<90 mm Hg, but the target is <130/<80 mm Hg for patients ...

Significant blood pressure reductions among patients with uncontrolled or resistant hypertension treated with lorundrostat reinforce key role of dysregulated aldosterone in disease onset and ...

Use this blood pressure chart to interpret your blood pressure readings and monitor this important heart health metric from ...

Mineralys is a clinical-stage biopharmaceutical ... from the Phase 2 Advance-HTN trial evaluating the efficacy and safety of lorundrostat for the treatment of uncontrolled hypertension (uHTN ...

High blood pressure, aka hypertension, can lead to heart disease or stroke if left uncontrolled. Here's what medical experts consider to be high blood pressure, how to know if you have it ...

Mineralys Therapeutics on Monday reported positive topline results from a pair of pivotal studies of its lorundrostat drug candidate for the treatment of uncontrolled or resistant hypertension.

A research team has investigated structural changes in kidneys of patients with hypertension and type 2 diabetes ... damage to the kidneys at an early stage and before clinical symptoms appear.

DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...